121 related articles for article (PubMed ID: 17427942)
21. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
[TBL] [Abstract][Full Text] [Related]
22. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
[TBL] [Abstract][Full Text] [Related]
23. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
24. Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?
Guidez D; Behnke S; Halmer R; Dillmann U; Faßbender K; Kirsch CM; Hellwig D; Spiegel J
J Neurol; 2014 Jan; 261(1):45-51. PubMed ID: 24136584
[TBL] [Abstract][Full Text] [Related]
25. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
26. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
Kashihara K; Ohno M; Kawada S; Okumura Y
J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
[TBL] [Abstract][Full Text] [Related]
27. Cardiac 123I-MIBG scintigraphy in patients with essential tremor.
Lee PH; Kim JW; Bang OY; Joo IS; Yoon SN; Huh K
Mov Disord; 2006 Aug; 21(8):1235-8. PubMed ID: 16671077
[TBL] [Abstract][Full Text] [Related]
28. Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.
Mitsui J; Saito Y; Momose T; Shimizu J; Arai N; Shibahara J; Ugawa Y; Kanazawa I; Tsuji S; Murayama S
J Neurol Sci; 2006 Apr; 243(1-2):101-4. PubMed ID: 16442563
[TBL] [Abstract][Full Text] [Related]
29. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.
Yoshita M
J Neurol Sci; 1998 Feb; 155(1):60-7. PubMed ID: 9562324
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease.
Shindo K; Kaneko E; Watanabe H; Sugimoto T; Ohta E; Ohashi K; Nagasaka T; Shiozawa Z
Mov Disord; 2005 Nov; 20(11):1419-24. PubMed ID: 16007621
[TBL] [Abstract][Full Text] [Related]
32. Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.
Suzuki M; Nakamura T; Hirayama M; Ueda M; Katsuno M; Sobue G
J Neurol; 2017 Feb; 264(2):333-340. PubMed ID: 27900499
[TBL] [Abstract][Full Text] [Related]
33. Myocardial MIBG scintigraphy may predict the course of motor symptoms in Parkinson's disease.
Dorschner J; Farmakis G; Behnke S; Hellwig D; Schneider S; Fassbender K; Kirsch CM; Dillmann U; Spiegel J
Parkinsonism Relat Disord; 2011 Jun; 17(5):372-5. PubMed ID: 21421334
[TBL] [Abstract][Full Text] [Related]
34. Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease.
Nakamura T; Hirayama M; Ito H; Takamori M; Hamada K; Takeuchi S; Watanabe H; Koike Y; Sobue G
J Neurol Sci; 2007 Dec; 263(1-2):133-8. PubMed ID: 17673233
[TBL] [Abstract][Full Text] [Related]
35. [Early alterations of adrenergic cardiac function in Parkinson's disease].
Campos V; Rebollo AC; Jiménez-Hoyuela JM; Gómez-Doblas JJ; Medialdea P; Vila E; Gutiérrez-Hurtado A
Neurologia; 2004 Mar; 19(2):53-8. PubMed ID: 14986180
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of orthostatic hypotension in Parkinson's disease.
Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Ito Y; Inoue K
Brain; 2007 Sep; 130(Pt 9):2425-32. PubMed ID: 17673498
[TBL] [Abstract][Full Text] [Related]
37. Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease.
Tsujikawa K; Hasegawa Y; Yokoi S; Yasui K; Nanbu I; Yanagi T; Takahashi A
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):945-51. PubMed ID: 25935888
[TBL] [Abstract][Full Text] [Related]
38. Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson's disease.
Haqparwar J; Pepe A; Fassbender K; Dillmann U; Ezziddin S; Schaefer A; Leppert D; Spiegel J
Parkinsonism Relat Disord; 2017 Jan; 34():26-30. PubMed ID: 27769648
[TBL] [Abstract][Full Text] [Related]
39. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
